When Parkinson's disease presents alongside cognitive impairment and psychotic symptoms, standard management approaches require careful reassessment. This protocol outlines the structured evidence-based response to this specific clinical scenario.
Parkinson's disease in a patient with concurrent psychotic symptoms and cognitive impairment. The presence of these features directly shapes which interventions are appropriate and in what order they are considered.
In patients where cognitive impairment is present and initial general measures have not been sufficient, the evidence supports a switch to a particular class of agent. The full protocol details the exact criteria, agent selection, and sequencing — access it below.
DOI: 10.1186/s42466-024-00325-4
In case of cognitive impairment and failure of the general measures, a switch to an acetylcholinesterase inhibitor can be offered.
View source ↗